BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for COBAS INTEGRA 400/400 plus systems, Roche

Product group In-vitro diagnostics
Reference 04263/07

Corrective action of Roche Diagnostics because of carry-over from LDL-Cholesterol assay to Lipase assay on COBAS INTEGRA 400/400 plus and from LDL-Cholesterol assay to the Lipase assay on cobas c 111. The customers were informed about the problem and how to avoid it.

Corrective action for COBAS INTEGRA 400/400 plus systems, Roche , Download_VeroeffentlichtAm_EN PDF, 336KB, File does not meet accessibility standards